Kanamycin Sulfate API is a pharmaceutical-grade aminoglycoside antibiotic with broad-spectrum bactericidal activity against susceptible Gram-negative and selected Gram-positive bacteria. It acts by irreversibly binding to the 30S bacterial ribosomal subunit, inhibiting protein synthesis and causing bacterial cell death.
Kanamycin Sulfate is widely used in the treatment of severe systemic infections, including respiratory tract infections, urinary tract infections, septicemia, bone and joint infections, and is also utilized as a second-line agent in multidrug-resistant tuberculosis (MDR-TB) treatment. Additionally, it is incorporated into ophthalmic, oral, and injectable pharmaceutical formulations.
Manufactured under WHO-GMP-certified facilities, our Kanamycin Sulfate API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, potency, stability, and batch-to-batch consistency. Every batch undergoes rigorous quality testing and is supplied with complete documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Kanamycin Sulfate API is used in injectable, oral, and ophthalmic pharmaceutical formulations for the treatment of serious bacterial infections and as a second-line therapy for multidrug-resistant tuberculosis.
Kanamycin Sulfate binds to the 30S bacterial ribosome, preventing protein synthesis and resulting in rapid bacterial cell death.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Kanamycin Sulfate API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp